TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 3nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MARK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 9nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MARK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incu...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 31nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 83nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 83nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 170nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 170nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 170nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 170nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 207nMAssay Description:Binding affinity to human MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 270nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 310nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 620nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 620nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 700nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.20E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.20E+3nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.20E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.20E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.40E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.50E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.50E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 1.50E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 2.30E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 2.30E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 2.30E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.00E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.00E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.20E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.90E+3nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.90E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.90E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: 4.90E+3nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to MARK1More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MARK1(Homo sapiens (Human))
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Takeda Pharmaceutical Company Limited
Curated by ChEMBL
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MARK1 kinase domainMore data for this Ligand-Target Pair